Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Alessandra Ferrario, Ph.D.

Concepts (122)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Drugs, Essential42020731.880 Why?
Drug Costs7202011051.040 Why?
Economics, Pharmaceutical42017871.010 Why?
National Health Programs220164450.810 Why?
Health Planning120232380.800 Why?
Health Services Accessibility5201851370.760 Why?
Geographic Information Systems120232810.760 Why?
Drug Industry320177460.740 Why?
Counterfeit Drugs1201620.600 Why?
Marketing of Health Services120181530.580 Why?
Fees, Medical120161170.520 Why?
Drugs, Generic120204210.500 Why?
Drug Utilization1202011830.470 Why?
Diabetes Complications3201413590.440 Why?
Antineoplastic Agents42020136950.420 Why?
Drug Approval120187420.400 Why?
Europe5201833390.380 Why?
International Cooperation1201714200.380 Why?
Cost of Illness3201418590.370 Why?
Models, Economic120147130.360 Why?
Health Policy4202026610.360 Why?
Pharmaceutical Preparations1201710710.340 Why?
Insurance, Health, Reimbursement320183970.330 Why?
Terminal Care1202016940.330 Why?
Thailand320202960.320 Why?
Europe, Eastern32017750.320 Why?
Diabetes Mellitus2201857510.300 Why?
Health Care Costs3201432090.280 Why?
Health Expenditures3201823480.280 Why?
Technology Assessment, Biomedical320193060.280 Why?
Decision Support Techniques1201419560.240 Why?
Breast Neoplasms22022208220.230 Why?
Mediterranean Region12023470.230 Why?
Diabetes Mellitus, Type 242014117250.230 Why?
Melanoma1202255100.220 Why?
Commerce220205920.220 Why?
Quality of Health Care2201843710.220 Why?
Indonesia220201190.210 Why?
Comparative Genomic Hybridization120234960.210 Why?
Evidence-Based Medicine1201436100.210 Why?
Kazakhstan12020140.190 Why?
Chronic Disease1201691460.190 Why?
European Union220191580.190 Why?
Philippines12020860.190 Why?
Malaysia12020920.180 Why?
Costs and Cost Analysis2201716810.170 Why?
Drug Prescriptions2202016370.170 Why?
Diabetes Mellitus, Type 11201433360.170 Why?
Chromosome Deletion1202314010.170 Why?
Gift Giving12018800.150 Why?
Cost Control120206240.150 Why?
World Health Organization1202313180.150 Why?
Belgium120161030.150 Why?
Scotland120161550.140 Why?
Reimbursement Mechanisms220206700.140 Why?
Moldova12016150.140 Why?
Humans2620237443430.140 Why?
Poverty2201826600.130 Why?
Endpoint Determination120186010.130 Why?
Policy Making120195540.130 Why?
Likelihood Functions1201810050.120 Why?
Algeria1201450.120 Why?
China1202022480.120 Why?
Delivery of Health Care3201753190.120 Why?
Sweden1201613450.120 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma1202015190.100 Why?
Chi-Square Distribution1201835080.100 Why?
Neoplasms12020216830.100 Why?
Prevalence42014152260.090 Why?
United States42023698720.090 Why?
Public Health1202326030.090 Why?
Income1201819130.090 Why?
Genotype12023129510.080 Why?
Cohort Studies22022405610.080 Why?
India1201421970.080 Why?
Regression Analysis1201864590.080 Why?
Benchmarking1201410420.080 Why?
Patient Care120136400.080 Why?
Kaplan-Meier Estimate1201865380.070 Why?
Decision Making2201938870.070 Why?
Needs Assessment1201311470.070 Why?
Palliative Care1202234930.070 Why?
Phenotype12023163650.070 Why?
Databases, Factual1202077290.060 Why?
Treatment Outcome32018631140.060 Why?
Attitude of Health Personnel1201838430.060 Why?
Developing Countries1201628150.060 Why?
Healthcare Disparities1201831580.050 Why?
Medicare1202065660.050 Why?
Cost-Benefit Analysis1201453910.050 Why?
Hospitalization12020102620.050 Why?
Socioeconomic Factors1201477850.050 Why?
Administrative Personnel120191870.040 Why?
Time Factors12018400750.030 Why?
Nigeria120187330.030 Why?
Family Practice120185160.030 Why?
Prospective Studies12018532880.030 Why?
Female320223801940.030 Why?
Switzerland120132550.030 Why?
France120135170.030 Why?
Cooperative Behavior1201915040.020 Why?
Germany120138620.020 Why?
Diabetic Neuropathies120134000.020 Why?
Australia1201311700.020 Why?
Brazil1201312700.020 Why?
Pharmacogenetics120136750.020 Why?
Aged120201632800.020 Why?
Male220233501180.020 Why?
Canada1201320650.020 Why?
Prescription Drugs120135950.020 Why?
Forecasting1201329510.010 Why?
Feasibility Studies1201350780.010 Why?
Population Surveillance1201326160.010 Why?
Infant, Newborn12020256250.010 Why?
Physicians1201845670.010 Why?
Infant12020351360.010 Why?
Child, Preschool12020410060.010 Why?
Cross-Sectional Studies12018250430.010 Why?
Child12020777090.010 Why?
Adolescent12020857810.010 Why?
Middle Aged120182133830.000 Why?
Adult120182140550.000 Why?
Ferrario's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (122)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.